1. Home
  2. Browse
  3. HRA002822
HRA002822
   HRA002822.xlsx
Title:
Stage IIIB or IV Non-small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
Release date:
2022-08-15
Description:
A Phase Ib Clinical Study to Evaluate the Safety and Efficacy of JMT101 in Combination with Afatinib or Osimertinib in Stage IIIB or IV Non-small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA010856
Study type:
Cohort Study
Disease name:
non-small cell lung carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC000235
DAC name:
Li zhang
Contact person:
Zhang Li
Email:
zhangli@sysucc.org.cn
Description:
Professor Li zhang is responsible for data release
Individuals & samples
Files
Request Data
Submitter:   Zhang Li / zhangli@sysucc.org.cn
Organization:   Sun Yat-sen University Cancer Center
Submission date:   2022-07-28
Requests:   -